#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Angiosarcoma non-metastatic Blood iron increased Fms-like tyrosine kinase 3 positive Neuroendocrine tumour of the lung B-cell small lymphocytic lymphoma Deafness bilateral Dilated cardiomyopathy Burkitt's lymphoma refractory Immune-mediated renal disorder Osteosarcoma Sarcoma Hereditary optic atrophy Paroxysmal nocturnal haemoglobinuria Chronic graft versus host disease in intestine Small cell lung cancer extensive stage More trials…

    Learn about Rare Diseases

    Netherton’s syndrome – Life with Disease Proteus syndrome – Treatment Bronchopulmonary dysplasia – Basic Information Synovial sarcoma – Treatment Lymphatic malformation Erdheim-Chester disease – Life with Disease Ocular melanoma Congenital hypotransferrinaemia – Trials in Disease Mantle cell lymphoma stage IV – Basic Information Rhabdomyosarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abiraterone Tipapkinogene Sovacivec Gadoteridol Benserazide Hydrochloride Caspofungin Desoximetasone Lifileucel Arginine Pentosan Polysulfate Sodium Melphalan Hydrochloride Aluminium Oxide, Hydrated Cls12311 Paltusotine Carfilzomib Dapagliflozin Propanediol Corifollitropin Alfa Abc-16F-116 Cendakimab Thalidomide Utreloxastat More therapies…

    Learn about Your Condition

    Neonatal hyperglycaemia Multiple system atrophy Carotid artery occlusion Hepatic fibrosis Pneumonia bacterial Actinic cheilitis Dry eye Mucopolysaccharidosis III Bile duct adenocarcinoma Tinnitus Eye disorder Angelman's syndrome Endometrial cancer metastatic Spinal cord injury Hypochondroplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on Avoiding Anticoagulation with Apixaban for Patients with Intracerebral Hemorrhage

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Apixaban
    France

  • Study on Anakinra for Patients with Intracerebral Hemorrhage to Reduce Brain Swelling After Stroke

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Anakinra
    The Netherlands

  • Study on the Safety and Effectiveness of IncobotulinumtoxinA for Treating Limb Spasticity in Children with Cerebral Palsy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Muscle spasticity
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Italy

  • Study on the Effects of Fludrocortisone in Treating Neurogenic Orthostatic Hypotension in Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Orthostatic hypotension
    Investigated Drugs:
    • Fludrocortisone Acetate
    France

  • Efficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial

    Recruiting

    3 1
    Investigated Diseases:
    • Huntington’s disease
    Investigated Drugs:
    • VOTOPLAM
    Austria Belgium Bulgaria Czechia Denmark Finland +14

  • Study of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Central nervous system lymphoma
    Investigated Drugs:
    • Rituximab
    • Temozolomide
    Austria Belgium Czechia France Germany Italy +2
Previous Page
1 … 55 56 57 58 59 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!